Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples

Area of Science:

• Pharmacology
• Biochemistry
• Toxicology

Background:

• Cytochrome P450 (CYP) enzymes are crucial for drug metabolism in humans.
• CYP3A isoforms are particularly important, metabolizing a majority of known drug substrates.
• Understanding animal models that mimic human CYP activity is vital for preclinical drug development.

Purpose of the Study:

• To investigate the presence and activity of Cytochrome P450 (CYP) enzymes, specifically the CYP3A family, in minipig liver microsomes.
• To compare CYP enzyme activities in minipigs with those in human liver microsomes.
• To evaluate the suitability of minipigs as an animal model for predicting human drug biotransformation.

Main Methods:

• Immunochemical screening (Western blotting) was used to detect CYP3A in minipig liver microsomes.
• Enzyme activities specific for CYP3A (nifedipine oxidase, testosterone 6beta-hydroxylating) were measured and compared between minipigs and humans.
• Specific CYP marker activities (CYP1A, 2A, 2C, 2D, 2E1, 2B) were assessed using specific substrates and inhibitors.

Main Results:

• Minipig liver microsomes showed bands co-migrating with human CYP3A4 and 3A5 via Western blotting.
• Comparable nifedipine oxidase and testosterone 6beta-hydroxylating activities were observed in minipig and human liver microsomes, with similar inhibition by triacetyloleandomycin.
• Marker activities for CYP1A, 2A, 2C, 2D, and 2E1 were present in minipig liver microsomes, while CYP2B activity was absent, mirroring human samples.

Conclusions:

• Minipig liver microsomes possess functional CYP3A enzymes with comparable activity to humans.
• The presence of multiple CYP isoforms and similar CYP3A activity makes minipigs a suitable model for predicting human drug biotransformation.
• Minipigs offer a valuable preclinical model for drug metabolism studies without the need for enzyme induction.